409 related articles for article (PubMed ID: 33710622)
1. Antibiotic therapy in sepsis: No next time for a second chance!
Shahrami B; Sharif M; Sefidani Forough A; Najmeddin F; Arabzadeh AA; Mojtahedzadeh M
J Clin Pharm Ther; 2021 Aug; 46(4):872-876. PubMed ID: 33710622
[TBL] [Abstract][Full Text] [Related]
2. Key Challenges in Providing Effective Antibiotic Therapy for Critically Ill Patients with Bacterial Sepsis and Septic Shock.
Landersdorfer CB; Nation RL
Clin Pharmacol Ther; 2021 Apr; 109(4):892-904. PubMed ID: 33570163
[TBL] [Abstract][Full Text] [Related]
3. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?
Blot S; Lipman J; Roberts DM; Roberts JA
Diagn Microbiol Infect Dis; 2014 May; 79(1):77-84. PubMed ID: 24602849
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.
Hagel S; Fiedler S; Hohn A; Brinkmann A; Frey OR; Hoyer H; Schlattmann P; Kiehntopf M; Roberts JA; Pletz MW;
Trials; 2019 Jun; 20(1):330. PubMed ID: 31171029
[TBL] [Abstract][Full Text] [Related]
5. [Adequate anti-infective treatment : Importance of individual dosing and application].
Brinkmann A; Röhr AC; Köberer A; Fuchs T; Krüger WA; König C; Richter D; Weigand MA; Frey OR
Anaesthesist; 2018 Jun; 67(6):461-476. PubMed ID: 29766208
[TBL] [Abstract][Full Text] [Related]
6. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic drug monitoring of β-lactam antibiotics in the ICU.
Dhaese S; Van Vooren S; Boelens J; De Waele J
Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263
[TBL] [Abstract][Full Text] [Related]
8. Can we transfer pharmacokinetics/pharmacodynamics of antimicrobials into clinical practice?
Scaglione F
Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S40-2. PubMed ID: 26607342
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Roberts JA; Lipman J
Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock.
Varghese JM; Roberts JA; Lipman J
Crit Care Clin; 2011 Jan; 27(1):19-34. PubMed ID: 21144984
[TBL] [Abstract][Full Text] [Related]
11. Bacterial sepsis : Diagnostics and calculated antibiotic therapy.
Richter DC; Heininger A; Brenner T; Hochreiter M; Bernhard M; Briegel J; Dubler S; Grabein B; Hecker A; Kruger WA; Mayer K; Pletz MW; Storzinger D; Pinder N; Hoppe-Tichy T; Weiterer S; Zimmermann S; Brinkmann A; Weigand MA; Lichtenstern C
Anaesthesist; 2019 Feb; 68(Suppl 1):40-62. PubMed ID: 29383395
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients.
D'Avolio A; Pensi D; Baietto L; Pacini G; Di Perri G; De Rosa FG
Drugs; 2016 Aug; 76(12):1161-74. PubMed ID: 27412121
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic dosing in critically ill patients with acute kidney injury.
Eyler RF; Mueller BA;
Nat Rev Nephrol; 2011 Apr; 7(4):226-35. PubMed ID: 21343897
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring of carbapenem antibiotics in critically ill patients: an overview of principles, recommended dosing regimens, and clinical outcomes.
Joynt GM; Ling L; Wong WT; Lipman J
Expert Rev Clin Pharmacol; 2023; 16(8):703-714. PubMed ID: 36942827
[TBL] [Abstract][Full Text] [Related]
15. Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study.
Fleuren LM; Roggeveen LF; Guo T; Waldauf P; van der Voort PHJ; Bosman RJ; Swart EL; Girbes ARJ; Elbers PWG
Crit Care; 2019 May; 23(1):185. PubMed ID: 31118061
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.
Carrié C; Delzor F; Roure S; Dubuisson V; Petit L; Molimard M; Breilh D; Biais M
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964795
[TBL] [Abstract][Full Text] [Related]
17. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
[TBL] [Abstract][Full Text] [Related]
18. Using PK/PD to optimize antibiotic dosing for critically ill patients.
Roberts JA
Curr Pharm Biotechnol; 2011 Dec; 12(12):2070-9. PubMed ID: 21554211
[TBL] [Abstract][Full Text] [Related]
19. [Bacterial sepsis : Diagnostics and calculated antibiotic therapy].
Richter DC; Heininger A; Brenner T; Hochreiter M; Bernhard M; Briegel J; Dubler S; Grabein B; Hecker A; Krüger WA; Mayer K; Pletz MW; Störzinger D; Pinder N; Hoppe-Tichy T; Weiterer S; Zimmermann S; Brinkmann A; Weigand MA; Lichtenstern C
Anaesthesist; 2017 Oct; 66(10):737-761. PubMed ID: 28980026
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic Stewardship and Therapeutic Drug Monitoring of β-Lactam Antibiotics: Is There a Link? An Opinion Paper.
Richter DC; Heininger A; Chiriac U; Frey OR; Rau H; Fuchs T; Röhr AC; Brinkmann A; Weigand MA
Ther Drug Monit; 2022 Feb; 44(1):103-111. PubMed ID: 34857694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
